The University of Tsukuba is located in the suburbs of Tokyo and is at the heart of Tsukuba Science City —Japan’s largest “science city,” which has 29 national research institutes and about 150 private research organizations. The University operates on the principle that it is open to all.
The University of Tsukuba aims to cross the borders that separate a variety of organizations, such as those between nations, research institutions, and fields of study. The University’s network is expanding globally. In particular, the University has entered into ten campus-in-campus arrangements with universities in eight countries and regions, thereby promoting close cooperative relationships between education and research. At present, the University hosts approximately 2,200 study abroad students from more than 110 countries and regions.
Collaboration is essential in order to achieve high-quality outcomes with limited resources. As an example, the University is actively engaged in an exchange of talent and joint research that goes beyond the conventional university framework at nationwide joint-use institutes that encompass the four fields of computational science, marine science, plant science, and plasma research.
The Research and Development Centers are the part of the University’s quest to pursue research and innovation that result in benefits for society. Externally funded, twelve centers are newly established as industry-university-government partnerships for joint research in areas of high demand from the community.
The University is also proactively engaging in the support of venture corporations. Thus far, a total of 160 companies have originated from the University of Tsukuba, including Cyberdyne, Inc.
A frontrunner in university reform in Japan, the University is creating a flexible education and research structure as well as a university system to meet the needs of the next generation. It aspires to be a comprehensive university, continuously meeting new challenges and developing new areas. The foremost mission of a university is to provide an environment that allows future leaders to realize their full potential. The University gives students the opportunity to develop their individuality and skills through an education that is backed by cutting-edge research.
The University of Tsukuba retains sole responsibility for content. © 2021 The University of Tsukuba.
1 December 2019 - 30 November 2020
Subject/journal group: All
The table to the right includes counts of all research outputs for University of Tsukuba published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Outputs by subject (Share)
|Angewandte Chemie International Edition||5||1.27|
|Journal of the American Chemical Society||5||1.40|
|Proceedings of the National Academy of Sciences of the United States of America||2||0.73|
|The Journal of Physical Chemistry Letters||2||0.93|
|Earth & Environmental Sciences||14||5.04|
Highlight of the month
Dangerous drug could lead to safe sleeping pills
© Peter Dazeley/The Image Bank/Getty Images
The sleep-promoting effects of thalidomide involve a different molecular pathway than the one responsible for the drug’s most notorious side effect, a mouse study has found.
Thalidomide was once used to treat morning sickness in pregnant women until it was found to cause birth defects. Thalidomide’s toxicity occurs because of the drug’s binding to a protein called cereblon, a key regulator of the cell’s rubbish-disposal system.
Now, a team led by researchers at the University of Tsukuba in Japan has found that it may be possible to chemically modify the drug such that it does not interfere with foetal development but keeps its anti-insomnia benefits.
Using mice that produced a thalidomide-resistant version of cereblon, the researchers found that the drug still enhanced sleep — in particular, a desirable type of slumber known as non-REM sleep. This indicates that thalidomide’s sleep-promoting effects are independent of cereblon. Future thalidomide-like agents that avoid cereblon-binding entirely could thus offer a safe option for treating insomnia.
- PNAS 117, 23106–23112 (2020). doi: 10.1073/pnas.1917701117
See more research highlights from University of Tsukuba
31 Jan 2021
24 Dec 2020
30 Sep 2020
31 Aug 2020
Top articles by Altmetric score in current window
1 December 2019 - 30 November 2020
International vs. domestic collaboration by Share
- 41.91% Domestic
- 58.09% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (163 total)
- University of Tsukuba, Japan
- Domestic institution
The University of Tokyo (UTokyo), Japan
National Institute of Advanced Industrial Science and Technology (AIST), Japan
National Institute for Materials Science (NIMS), Japan
Kyoto University, Japan
Tohoku University, Japan
Osaka University, Japan
Kyushu University, Japan
Hokkaido University, Japan
Keio University, Japan
Top 10 international collaborators by Share (848 total)
- University of Tsukuba, Japan
- Foreign institution
French National Centre for Scientific Research (CNRS), France
National Institute for Nuclear Physics (INFN), Italy
European Organization for Nuclear Research (CERN), Switzerland
Helmholtz Association of German Research Centres, Germany
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)
University of Michigan (U-M), United States of America (USA)
Nanjing University (NJU), China
Massachusetts Institute of Technology (MIT), United States of America (USA)
Chinese Academy of Sciences (CAS), China
Shanghai Jiao Tong University (SJTU), China
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Affiliated joint institutions and consortia
- ALICE Collaboration, Switzerland
- CDF Collaboration, United States of America (USA)
- Expedition 302 Scientists, Sweden
- Expedition 343 Scientists, Japan
- Japanese Association for Marine Biology (JAMBIO), Japan
- Multiproxy Approach for the Reconstruction of the Glacial Ocean Surface (MARGO), Germany
- PHENIX Collaboration, United States of America (USA)
- The ATLAS Collaboration, Switzerland
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.